William XIANG

JOB TITLE
Co-Founder, President and COO
DEPARTMENT
Protuoso Biosciences / Executive
INSTRUCTION LANGUAGES
  • English
Protuoso Biosciences
PERSONAL BIO

Willie is Co-Founder, President, and Chief Operating Officer of Protuoso Biosciences. Previously, he served as Head of Strategy, Business Development, and R&D Operations at XWPharma, a venture-backed neuroscience biotechnology company focused on novel drug discovery and development. There, he built capital-efficient, cross-border teams and led integrated R&D execution across CMC, nonclinical, clinical, regulatory, and medical functions, shaping program strategy and driving advancement from preclinical development through registrational and Phase II clinical studies. Across emerging biotechs, Willie has been instrumental in raising over US$100 million in financing and securing more than US$1 billion in total deal value through strategic transactions.

He is passionate about advancing biotech entrepreneurship and career development, and has founded and served as an executive of nonprofit organizations dedicated to supporting the next generation of industry leaders. Willie holds an MBA from the University of Chicago Booth School of Business and a BSc from Haverford College.

WORK EXPERIENCE AND AWARDS
  • Co-Founder, President and Chief Operating Officer, Protuoso Biosciences, USA (2025 – present)
  • Nucleate (Non-Profit), USA
    • Executive Vice President of Organizational Development (2024 – 2025)
    • Vice President of Talent Management (2023 – 2024)
    • Founder and Managing Director, Nucleate Taiwan (2023 – 2024)
  • Head of Strategy, Business Development and R&D Operations, XWPharma, USA (2016 – 2025)
EDUCATIONAL BACKGROUND
  • MBA, University of Chicago Booth School of Business, USA
  • BSc, Haverford College, USA
Job Positions